FDA panel endorses Pfizer’s COVID-19 vaccine for children 5-11
An FDA panel of outside vaccine experts endorsed kid-sized doses of Pfizer’s COVID-19 vaccine for U.S. children aged 5 to 11.
An FDA panel of outside vaccine experts endorsed kid-sized doses of Pfizer’s COVID-19 vaccine for U.S. children aged 5 to 11.
